LEADER 01497nas  2200505-  450 
001 9910213560203321
005 20240914213022.0
011   $a2002-3294
035   $a(DE-599)ZDB2912034-2
035   $a(OCoLC)972035334
035   $a(CKB)3710000001069019
035   $a(CONSER)--2020204347
035   $a(EXLCZ)993710000001069019
100   $a20161026b20162019  ---         a
101 0 $aeng
135   $aurunu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aClaustrum
210  1$a[Järfälla, Sweden] :$cCo-Action Publishing,$d2016-2019.
210 31$a[Abingdon] :$cInforma UK Limited, trading as Taylor & Francis Group
300   $aRefereed/Peer-reviewed
606   $aBrain$xAnatomy$vPeriodicals
606   $aClaustrum$vPeriodicals
606   $aBasal Ganglia
606   $aBrain$xanatomy & histology
606   $aNeurosciences
606   $aBrain$xAnatomy$2fast$3(OCoLC)fst00837578
606   $aClaustrum$2fast$3(OCoLC)fst00863779
606   $aAvant-mur (Neuroanatomie)$vPériodiques
608   $aPeriodicals.$2fast
615  0$aBrain$xAnatomy
615  0$aClaustrum
615 12$aBasal Ganglia.
615 12$aBrain$xanatomy & histology.
615 12$aNeurosciences.
615  7$aBrain$xAnatomy.
615  7$aClaustrum.
615  6$aAvant-mur (Neuroanatomie)
676   $a611.81
906   $aJOURNAL
912   $a9910213560203321
996   $aClaustrum$91976689
997   $aUNINA

LEADER 02982nam  2200949zu 450 
001 9910689427003321
005 20251017110056.0
035   $a(CKB)2670000000410510
035   $a(SSID)ssj0000621032
035   $a(PQKBManifestationID)11400692
035   $a(PQKBTitleCode)TC0000621032
035   $a(PQKBWorkID)10616585
035   $a(PQKB)24890520
035   $a(WaSeSS)Innodata00030226
035   $a(OCoLC)53784787
035 9 $aocm53784787
035   $a(OCoLC)992670000000410510
035   $a(DNLM)1562065
035   $a(EXLCZ)992670000000410510
100   $a20160829d2001      uy 
101 0 $aeng
135   $aur|||||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aManagement of acne
210 31$a[Place of publication not identified]$cU S Dept of Health and Human Services Public Health Service Agency for Healthcare Research and Q$d2001
215   $a1 online resource
225 0 $aAHRQ publication  Management of acne
300   $aBibliographic Level Mode of Issuance: Monograph
320   $aIncludes bibliographical references.
327   $av. 1. Evidence report and appendixes -- v. 2. Evidence tables and bibliography.
410  0$aEvidence report/technology assessment ;$vno. 17.
410  0$aAHRQ publication ;$vno. 01-E019.
606   $aAcne
606   $aSebaceous Gland Diseases
606   $aClinical Medicine
606   $aAcneiform Eruptions
606   $aInvestigative Techniques
606   $aEvidence-Based Practice
606   $aMedicine
606   $aFacial Dermatoses
606   $aSkin Diseases
606   $aHealth Occupations
606   $aDiagnostic Techniques and Procedures
606   $aSkin and Connective Tissue Diseases
606   $aDisease
606   $aEvidence-Based Medicine
606   $aAcne Vulgaris
606   $aMethods
606   $aMedicine$2HILCC
606   $aHealth & Biological Sciences$2HILCC
606   $aDermatology$2HILCC
608   $aMeta-Analysis.$2mesh
615  0$aAcne.
615  2$aSebaceous Gland Diseases.
615  2$aClinical Medicine.
615  2$aAcneiform Eruptions.
615  2$aInvestigative Techniques.
615  2$aEvidence-Based Practice.
615  2$aMedicine.
615  2$aFacial Dermatoses.
615  2$aSkin Diseases.
615  2$aHealth Occupations.
615  2$aDiagnostic Techniques and Procedures.
615  2$aSkin and Connective Tissue Diseases.
615  2$aDisease.
615  2$aEvidence-Based Medicine.
615  2$aAcne Vulgaris.
615  2$aMethods.
615  7$aMedicine
615  7$aHealth & Biological Sciences
615  7$aDermatology
676   $a616.5/3
702   $aLehmann$b Harold P.
702   $aAndrews$b John S.
712 02$aUnited States Agency for Healthcare Research and Quality
801  0$bPQKB
906   $aBOOK
912   $a9910689427003321
996   $aManagement of acne$93138503
997   $aUNINA